Department of Medicine, Hertzberg Palliative Care Institute, Mount Sinai School of Medicine, New York, New York 10029, USA.
Am J Respir Crit Care Med. 2010 Aug 15;182(4):446-54. doi: 10.1164/rccm.201002-0210CI. Epub 2010 May 6.
Although advances in intensive care have enabled more patients to survive an acute critical illness, they also have created a large and growing population of chronically critically ill patients with prolonged dependence on mechanical ventilation and other intensive care therapies. Chronic critical illness is a devastating condition: mortality exceeds that for most malignancies, and functional dependence persists for most survivors. Costs of treating the chronically critically ill in the United States already exceed $20 billion and are increasing. In this article, we describe the constellation of clinical features that characterize chronic critical illness. We discuss the outcomes of this condition including ventilator liberation, mortality, and physical and cognitive function, noting that comparisons among cohorts are complicated by variation in defining criteria and care settings. We also address burdens for families of the chronically critically ill and the difficulties they face in decision-making about continuation of intensive therapies. Epidemiology and resource utilization issues are reviewed to highlight the impact of chronic critical illness on our health care system. Finally, we summarize the best available evidence for managing chronic critical illness, including ventilator weaning, nutritional support, rehabilitation, and palliative care, and emphasize the importance of efforts to prevent the transition from acute to chronic critical illness. As steps forward for the field, we suggest a specific definition of chronic critical illness, advocate for the creation of a research network encompassing a broad range of venues for care, and highlight areas for future study of the comparative effectiveness of different treatment venues and approaches.
尽管重症监护的进步使更多的患者能够在急性危重病中存活下来,但它也创造了一个庞大且不断增长的慢性危重病患者群体,这些患者需要长期依赖机械通气和其他重症监护治疗。慢性危重病是一种毁灭性的疾病:死亡率超过大多数恶性肿瘤,大多数幸存者仍存在功能依赖。美国治疗慢性危重病患者的成本已经超过 200 亿美元,并且还在不断增加。在本文中,我们描述了慢性危重病的临床特征组合。我们讨论了这种疾病的结局,包括呼吸机撤离、死亡率以及身体和认知功能,同时注意到,由于定义标准和护理环境的差异,不同队列之间的比较比较复杂。我们还讨论了慢性危重病患者家庭的负担以及他们在决定是否继续进行强化治疗时所面临的困难。我们回顾了流行病学和资源利用问题,以强调慢性危重病对我们的医疗保健系统的影响。最后,我们总结了管理慢性危重病的最佳现有证据,包括呼吸机脱机、营养支持、康复和姑息治疗,并强调了努力预防从急性到慢性危重病的转变的重要性。作为该领域的前进方向,我们建议对慢性危重病进行具体定义,倡导创建一个涵盖广泛护理场所的研究网络,并强调对不同治疗场所和方法的相对有效性进行未来研究的重要性。